Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD)

John Gilbert, J. M. Stajich, S. Wall, S. C. Carter, H. Qiu, Jeffery M Vance, C. S. Stewart, M. C. Speer, J. Pufky, L. H. Yamaoka, M. Rozear, F. Samson, M. Fardeau, A. D. Roses, Margaret A Pericak-Vance

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is a slowly progressive primary disease of muscle which is usually inherited as an autosomal dominant disorder. FSHD has been localized to the long arm of chromosome 4, specifically to the 4q3.5-qter region. Initially published linkage studies showed no evidence for heterogeneity in FSHD. In the present study we have examined individuals in seven FSHD families. Two-point lod scores show significant evidence for linkage for D4S163 (lod score 3.04 at recombination fraction .21) and D4S139 (lod score 3.84 at recombination fraction .20). D4S171 also gave a positive score (lod score 2.56 at recombination fraction .24). Significant evidence for heterogeneity was found for each of the three markers. Multipoint linkage analysis in this region resulted in a peak multipoint lod score of 6.47. The multipoint analysis supported the two-point studies with odds of 20:1 showing linkage and heterogeneity over linkage and homogeneity. Five of the seven families gave a posterior probability of >95% of being of the linked type, while two families appeared unlinked to this region of 4q (P < .01%). Individuals in the two unlinked families met the clinical criteria for the diagnosis of FSHD, including facial weakness, clavicular flattening, scapula winging, proximal muscle weakness, and myopathic changes on muscle biopsies without inflammatory or mitochondrial pathology. This study demonstrates genetic heterogeneity in FSHD and has important implications for both genetic counseling and the elucidation of the etiology of FSHD.

Original languageEnglish
Pages (from-to)401-408
Number of pages8
JournalAmerican Journal of Human Genetics
Volume53
Issue number2
StatePublished - Aug 1 1993
Externally publishedYes

Fingerprint

Facioscapulohumeral Muscular Dystrophy
Lod Score
Genetic Recombination
Scapula
Muscles
Chromosomes, Human, Pair 4
Genetic Heterogeneity
Muscle Weakness
Genetic Counseling
Pathology
Biopsy

ASJC Scopus subject areas

  • Genetics

Cite this

Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD). / Gilbert, John; Stajich, J. M.; Wall, S.; Carter, S. C.; Qiu, H.; Vance, Jeffery M; Stewart, C. S.; Speer, M. C.; Pufky, J.; Yamaoka, L. H.; Rozear, M.; Samson, F.; Fardeau, M.; Roses, A. D.; Pericak-Vance, Margaret A.

In: American Journal of Human Genetics, Vol. 53, No. 2, 01.08.1993, p. 401-408.

Research output: Contribution to journalArticle

Gilbert, J, Stajich, JM, Wall, S, Carter, SC, Qiu, H, Vance, JM, Stewart, CS, Speer, MC, Pufky, J, Yamaoka, LH, Rozear, M, Samson, F, Fardeau, M, Roses, AD & Pericak-Vance, MA 1993, 'Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD)', American Journal of Human Genetics, vol. 53, no. 2, pp. 401-408.
Gilbert J, Stajich JM, Wall S, Carter SC, Qiu H, Vance JM et al. Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD). American Journal of Human Genetics. 1993 Aug 1;53(2):401-408.
Gilbert, John ; Stajich, J. M. ; Wall, S. ; Carter, S. C. ; Qiu, H. ; Vance, Jeffery M ; Stewart, C. S. ; Speer, M. C. ; Pufky, J. ; Yamaoka, L. H. ; Rozear, M. ; Samson, F. ; Fardeau, M. ; Roses, A. D. ; Pericak-Vance, Margaret A. / Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD). In: American Journal of Human Genetics. 1993 ; Vol. 53, No. 2. pp. 401-408.
@article{761a99b12cc049bcbb766d89bdc8cba4,
title = "Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD)",
abstract = "Facioscapulohumeral muscular dystrophy (FSHD) is a slowly progressive primary disease of muscle which is usually inherited as an autosomal dominant disorder. FSHD has been localized to the long arm of chromosome 4, specifically to the 4q3.5-qter region. Initially published linkage studies showed no evidence for heterogeneity in FSHD. In the present study we have examined individuals in seven FSHD families. Two-point lod scores show significant evidence for linkage for D4S163 (lod score 3.04 at recombination fraction .21) and D4S139 (lod score 3.84 at recombination fraction .20). D4S171 also gave a positive score (lod score 2.56 at recombination fraction .24). Significant evidence for heterogeneity was found for each of the three markers. Multipoint linkage analysis in this region resulted in a peak multipoint lod score of 6.47. The multipoint analysis supported the two-point studies with odds of 20:1 showing linkage and heterogeneity over linkage and homogeneity. Five of the seven families gave a posterior probability of >95{\%} of being of the linked type, while two families appeared unlinked to this region of 4q (P < .01{\%}). Individuals in the two unlinked families met the clinical criteria for the diagnosis of FSHD, including facial weakness, clavicular flattening, scapula winging, proximal muscle weakness, and myopathic changes on muscle biopsies without inflammatory or mitochondrial pathology. This study demonstrates genetic heterogeneity in FSHD and has important implications for both genetic counseling and the elucidation of the etiology of FSHD.",
author = "John Gilbert and Stajich, {J. M.} and S. Wall and Carter, {S. C.} and H. Qiu and Vance, {Jeffery M} and Stewart, {C. S.} and Speer, {M. C.} and J. Pufky and Yamaoka, {L. H.} and M. Rozear and F. Samson and M. Fardeau and Roses, {A. D.} and Pericak-Vance, {Margaret A}",
year = "1993",
month = "8",
day = "1",
language = "English",
volume = "53",
pages = "401--408",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD)

AU - Gilbert, John

AU - Stajich, J. M.

AU - Wall, S.

AU - Carter, S. C.

AU - Qiu, H.

AU - Vance, Jeffery M

AU - Stewart, C. S.

AU - Speer, M. C.

AU - Pufky, J.

AU - Yamaoka, L. H.

AU - Rozear, M.

AU - Samson, F.

AU - Fardeau, M.

AU - Roses, A. D.

AU - Pericak-Vance, Margaret A

PY - 1993/8/1

Y1 - 1993/8/1

N2 - Facioscapulohumeral muscular dystrophy (FSHD) is a slowly progressive primary disease of muscle which is usually inherited as an autosomal dominant disorder. FSHD has been localized to the long arm of chromosome 4, specifically to the 4q3.5-qter region. Initially published linkage studies showed no evidence for heterogeneity in FSHD. In the present study we have examined individuals in seven FSHD families. Two-point lod scores show significant evidence for linkage for D4S163 (lod score 3.04 at recombination fraction .21) and D4S139 (lod score 3.84 at recombination fraction .20). D4S171 also gave a positive score (lod score 2.56 at recombination fraction .24). Significant evidence for heterogeneity was found for each of the three markers. Multipoint linkage analysis in this region resulted in a peak multipoint lod score of 6.47. The multipoint analysis supported the two-point studies with odds of 20:1 showing linkage and heterogeneity over linkage and homogeneity. Five of the seven families gave a posterior probability of >95% of being of the linked type, while two families appeared unlinked to this region of 4q (P < .01%). Individuals in the two unlinked families met the clinical criteria for the diagnosis of FSHD, including facial weakness, clavicular flattening, scapula winging, proximal muscle weakness, and myopathic changes on muscle biopsies without inflammatory or mitochondrial pathology. This study demonstrates genetic heterogeneity in FSHD and has important implications for both genetic counseling and the elucidation of the etiology of FSHD.

AB - Facioscapulohumeral muscular dystrophy (FSHD) is a slowly progressive primary disease of muscle which is usually inherited as an autosomal dominant disorder. FSHD has been localized to the long arm of chromosome 4, specifically to the 4q3.5-qter region. Initially published linkage studies showed no evidence for heterogeneity in FSHD. In the present study we have examined individuals in seven FSHD families. Two-point lod scores show significant evidence for linkage for D4S163 (lod score 3.04 at recombination fraction .21) and D4S139 (lod score 3.84 at recombination fraction .20). D4S171 also gave a positive score (lod score 2.56 at recombination fraction .24). Significant evidence for heterogeneity was found for each of the three markers. Multipoint linkage analysis in this region resulted in a peak multipoint lod score of 6.47. The multipoint analysis supported the two-point studies with odds of 20:1 showing linkage and heterogeneity over linkage and homogeneity. Five of the seven families gave a posterior probability of >95% of being of the linked type, while two families appeared unlinked to this region of 4q (P < .01%). Individuals in the two unlinked families met the clinical criteria for the diagnosis of FSHD, including facial weakness, clavicular flattening, scapula winging, proximal muscle weakness, and myopathic changes on muscle biopsies without inflammatory or mitochondrial pathology. This study demonstrates genetic heterogeneity in FSHD and has important implications for both genetic counseling and the elucidation of the etiology of FSHD.

UR - http://www.scopus.com/inward/record.url?scp=0027433246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027433246&partnerID=8YFLogxK

M3 - Article

VL - 53

SP - 401

EP - 408

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 2

ER -